Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Craufurd

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Plos Currents|October 13, 2011
NMDA receptor gene variations as modifiers in Huntington disease: a replication studyCarsten Saft, Jörg T Epplen, Stefan Wieczorek, et al.
Journal of Huntington'S Disease|March 1, 2021
Experiences of Mindfulness-Based Cognitive Therapy for Premanifest Huntington's DiseaseFiona J R Eccles, David Craufurd, Alistair Smith, et al.
Plos Currents|November 20, 2015
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's DiseaseAndrew C McCourt, Kirsty L O'Donovan, Eva Ekblad, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutationStuart Pickering-Brown, Matt Baker, Thomas Bird, et al.
Journal of Huntington'S Disease|July 27, 2014
Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partnersJoy Read, Rebecca Jones, Gail Owen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)Erik van Duijn, David Craufurd, Anna A M Hubers, et al.
Plos Currents|January 29, 2016
Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical PerformanceRuth Keogh, Chris Frost, Gail Owen, et al.
Plos Currents|November 29, 2011
Assessment of cognitive symptoms in prodromal and early huntington diseaseAnthony L Vaccarino, Terrence Sills, Karen E Anderson, et al.
Journal of Psychiatric Research|June 25, 2013
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) studyEric A Epping, James A Mills, Leigh J Beglinger, et al.
The Lancet. Neurology|May 14, 2013
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational dataSarah J Tabrizi, Rachael I Scahill, Gail Owen, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Plos Currents|October 13, 2011
NMDA receptor gene variations as modifiers in Huntington disease: a replication studyCarsten Saft, Jörg T Epplen, Stefan Wieczorek, et al.
Journal of Huntington'S Disease|March 1, 2021
Experiences of Mindfulness-Based Cognitive Therapy for Premanifest Huntington's DiseaseFiona J R Eccles, David Craufurd, Alistair Smith, et al.
Plos Currents|November 20, 2015
Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's DiseaseAndrew C McCourt, Kirsty L O'Donovan, Eva Ekblad, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutationStuart Pickering-Brown, Matt Baker, Thomas Bird, et al.
Journal of Huntington'S Disease|July 27, 2014
Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partnersJoy Read, Rebecca Jones, Gail Owen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2014
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)Erik van Duijn, David Craufurd, Anna A M Hubers, et al.
Plos Currents|January 29, 2016
Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical PerformanceRuth Keogh, Chris Frost, Gail Owen, et al.
Plos Currents|November 29, 2011
Assessment of cognitive symptoms in prodromal and early huntington diseaseAnthony L Vaccarino, Terrence Sills, Karen E Anderson, et al.
Journal of Psychiatric Research|June 25, 2013
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) studyEric A Epping, James A Mills, Leigh J Beglinger, et al.
The Lancet. Neurology|May 14, 2013
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational dataSarah J Tabrizi, Rachael I Scahill, Gail Owen, et al.
Pageof 7